Listen to our latest Investing Matters Podcast episode 'Uncovering opportunities with investment trusts' with The AIC's Richard Stone here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCLIN.L Share News (CLIN)

  • There is currently no data for CLIN

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

BROKER RATINGS SUMMARY: Berenberg Upgrades Meggitt To Buy From Hold

Tue, 15th Dec 2015 09:46

LONDON (Alliance News) - The following shares received analyst recommendations Tuesday morning and Monday:
----------
FTSE 100
----------
BERENBERG RAISES MEGGITT TO 'BUY' ('HOLD') - TARGET 445 (536) PENCE
----------
LIBERUM CUTS SPORTS DIRECT PRICE TARGET TO 810 (950) PENCE - 'BUY'
----------
BARCLAYS CUTS MARKS & SPENCER PRICE TARGET TO 500 (550) PENCE - 'EQUAL WEIGHT'
----------
UBS CUTS MARKS & SPENCER PRICE TARGET TO 630 (640) PENCE - 'BUY'
----------
DAVY CUTS WOLSELEY TO 'NEUTRAL' ('OUTPERFORM')
----------
GOLDMAN CUTS WOLSELEY TO 'NEUTRAL' ('BUY') - TARGET 4459 (4860) PENCE
----------
CREDIT SUISSE CUTS RANDGOLD RESOURCES PRICE TARGET TO 3900 (4040) P - 'NEUTRAL'
----------
CREDIT SUISSE CUTS ANTOFAGASTA PRICE TARGET TO 400 (500) PENCE - 'UNDERPERFORM'
----------
CREDIT SUISSE CUTS RIO TINTO PRICE TARGET TO 2100 (2400) PENCE - 'NEUTRAL'
----------
CREDIT SUISSE RAISES BHP BILLITON TO OUTPERFORM (NEUTRAL) - PRICE TARGET 900 (1100) PENCE
----------
CREDIT SUISSE CUTS ANGLO AMERICAN PRICE TARGET TO 320 (750) PENCE - 'NEUTRAL'
----------
JPMORGAN CUTS ANGLO AMERICAN PRICE TARGET TO 265 (450) PENCE - 'UNDERWEIGHT'
----------
UBS CUTS NEXT PRICE TARGET TO 7750 (7800) PENCE - 'NEUTRAL'
----------
GOLDMAN CUTS PERSIMMON PRICE TARGET TO 2200 (2205) PENCE - 'NEUTRAL'
----------
GOLDMAN RAISES BERKELEY GROUP PRICE TARGET TO 4100 (4075) PENCE - 'NEUTRAL'
----------
GOLDMAN RAISES BARRATT DEVELOPMENTS PRICE TARGET TO 690 (685) PENCE - 'NEUTRAL'
----------
GOLDMAN CUTS TRAVIS PERKINS TO 'NEUTRAL' ('BUY') - TARGET 2307 (2650) PENCE
----------
GOLDMAN CUTS UNILEVER PLC PRICE TARGET TO 2600 (2760) PENCE - 'SELL'
----------
FTSE 250
----------
JEFFERIES CUTS IMI PRICE TARGET TO 870 (1150) PENCE - 'HOLD'
----------
NOMURA RAISES IMI PRICE TARGET TO 972 (955) PENCE - 'BUY'
----------
JEFFERIES CUTS ESSENTRA PRICE TARGET TO 1000 (1025) PENCE - 'BUY'
----------
PANMURE RAISES AVEVA GROUP PRICE TARGET TO 1910 (1857) PENCE - 'HOLD'
----------
BARCLAYS CUTS SHAWBROOK PRICE TARGET TO 375 (410) PENCE - 'OVERWEIGHT'
----------
BARCLAYS CUTS ALDERMORE PRICE TARGET TO 225 (310) PENCE - 'EQUAL WEIGHT'
----------
BARCLAYS CUTS PARAGON GROUP TO 'EQUAL WEIGHT' (OVERWEIGHT) - TARGET 375 (475) PENCE
----------
BARCLAYS CUTS ONESAVINGS BANK TO EQUAL WEIGHT (OVERWEIGHT) - TARGET 340 (375) PENCE
----------
RBC CAPITAL INITIATES CIRCASSIA PHARMACEUTICALS WITH 'TOP PICK' - TARGET 430 P
----------
DAVY RAISES SIG TO 'OUTPERFORM' ('NEUTRAL')
----------
DAVY RAISES GRAFTON GROUP TO 'OUTPERFORM' ('NEUTRAL')
----------
RBC CAPITAL INITATES VECTURA AT 'OUTPERFORM' - TARGET 210 PENCE
----------
RBC CAPITAL INITIATES INDIVIOR WITH 'UNDERPERFORM' - TARGET 140 PENCE
----------
RBC CAPITAL INITIATES DECHRA PHARMA WITH 'SECTOR PERFORM' - TARGET 1080 PENCE
----------
RBC CAPITAL INITIATES BTG WITH 'OUTPERFORM' - TARGET 820 PENCE
----------
CREDIT SUISSE CUTS VEDANTA PRICE TARGET TO 230 (430) PENCE - 'UNDERPERFORM'
----------
JPMORGAN RAISES RPC GROUP PRICE TARGET TO 415 (360) PENCE - 'OVERWEIGHT'
----------
JPMORGAN INITIATES TELECOM PLUS WITH 'OVERWEIGHT' - TARGET 1290 PENCE
----------
UBS CUTS N BROWN PRICE TARGET TO 380 (395) PENCE - 'BUY'
----------
UBS CUTS HALFORDS GROUP PRICE TARGET TO 365 (380) PENCE - 'NEUTRAL'
----------
UBS CUTS DEBENHAMS PRICE TARGET TO 70 (72) PENCE - 'SELL'
----------
UBS CUTS B&M EUROPEAN VALUE RETAIL PRICE TARGET TO 390 (400) PENCE - 'BUY'
----------
GOLDMAN CUTS FOXTONS PRICE TARGET TO 227 (254) PENCE - 'NEUTRAL'
----------
GOLDMAN CUTS CREST NICHOLSON PRICE TARGET TO 750 (760) PENCE - 'CONVICTION BUY'
----------
HSBC CUTS JIMMY CHOO PRICE TARGET TO 160 (185) PENCE - 'BUY'
----------
GOLDMAN CUTS COUNTRYWIDE PRICE TARGET TO 498 (506) PENCE - 'NEUTRAL'
----------
HSBC RAISES GREENE KING TO 'HOLD' ('REDUCE') - TARGET 870 (780) PENCE
----------
GOLDMAN CUTS BOVIS HOMES PRICE TARGET TO 1295 (1440) PENCE - 'BUY'
----------
GOLDMAN RAISES BELLWAY PRICE TARGET TO 3390 (3200) PENCE - 'BUY'
----------
GOLDMAN RAISES BALFOUR BEATTY PRICE TARGET TO 296 (276) PENCE - 'NEUTRAL'
----------
NOMURA RAISES WEIR GROUP PRICE TARGET TO 1129 (1110) PENCE - 'NEUTRAL'
----------
NOMURA RAISES ROTORK PRICE TARGET TO 158 (155) PENCE - 'REDUCE'
----------
GOLDMAN RAISES REDROW TO 'BUY' ('NEUTRAL')
----------
GOLDMAN CUTS HOWDEN JOINERY TO 'SELL' ('NEUTRAL') - TARGET 565 (568) PENCE
----------
Liberum Cuts SuperGroup To Hold From Buy, Price Target 1,500p
----------
Numis Cuts Investec Price Target To 496p From 609p, Maintains Add
----------
MAIN MARKET AND AIM
----------
PEEL HUNT RAISES CARPETRIGHT PRICE TARGET TO 575 PENCE - 'BUY'
----------
JEFFERIES CUTS HARGREAVES SERVICES PRICE TARGET TO 270 (325) PENCE - 'HOLD'
----------
RBC CAPITAL INITIATES CLINIGEN WITH 'OUTPERFORM' - TARGET 770 PENCE
----------
CREDIT SUISSE CUTS FERREXPO PRICE TARGET TO 15 (30) PENCE - 'UNDERPERFORM'
----------
By Arvind Bhunjun; arvindbhunjun@alliancenews.com; @ArvindBhunjun

Copyright 2015 Alliance News Limited. All Rights Reserved.

More News
1 Apr 2022 20:22

IN BRIEF: UK court sanctions Titon takeover of Clinigen

Clinigen Group PLC - Burton On Trent, Staffordshire-based pharmaceutical services - Says Thursday that its takeover by Triton Investment Management Ltd has been sanctioned by the High Court of Justice in England and Wales. Shares will be cancelled from trading on AIM on Tuesday.

Read more
23 Feb 2022 19:06

TRADING UPDATES: IPF swings to profit; Seraphine lowers outlook

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Wednesday and not separately reported by Alliance News:

Read more
23 Feb 2022 13:28

Clinigen revenue rises as shareholders approve its acquisition

(Sharecast News) - Pharmaceuticals and service company Clinigen Group reported a 10% improvement in net revenue from continuing operations in its half-year results on Wednesday, or 14% on an organic basis, to £238.1m.

Read more
16 Feb 2022 10:09

IN BRIEF: Clinigen expects acquisition by Triton to complete in April

Clinigen Group PLC - Burton On Trent, Staffordshire-based pharmaceutical services - Says its acquisition by funds managed by Triton Investment Management Ltd is likely to complete in early April, with its shares due to be cancelled on AIM on April 5. The deal and timeline are subject to antitrust and foreign investment approvals. Triton, a private equity firm submitted a cash offer of 925 pence per share, valuing Clinigen at GBP1.3 billion, which was approved by shareholders last Tuesday. The latest date for completion is September 8.

Read more
9 Feb 2022 10:38

IN BRIEF: Clinigen signs global distribution deal for Qinlock

IN BRIEF: Clinigen signs global distribution deal for Qinlock

Read more
8 Feb 2022 14:41

IN BRIEF: Clinigen shareholders approve takeover by Triton funds

IN BRIEF: Clinigen shareholders approve takeover by Triton funds

Read more
17 Jan 2022 10:05

Triton increases takeover bid for Clinigen to GBP1.3 billion

Triton increases takeover bid for Clinigen to GBP1.3 billion

Read more
17 Jan 2022 07:29

Triton makes 'increased and final' 925p bid for Clinigen

(Sharecast News) - Clinigen announced an increased and final all-cash offer from Triton of 925p per share on Monday.

Read more
12 Jan 2022 11:49

Clinigen reiterates guidance after 'solid' first half

(Sharecast News) - Pharmaceutical products and services company Clinigen reiterated its guidance for EBITDA growth in the 2022 financial year of between 5% and 10% in a trading update on Wednesday.

Read more
12 Jan 2022 11:13

Clinigen holds earnings growth guidance after solid first half

Clinigen holds earnings growth guidance after solid first half

Read more
11 Jan 2022 14:59

CORRECT: UK shareholder meetings calendar - next 7 days

CORRECT: UK shareholder meetings calendar - next 7 days

Read more
11 Jan 2022 14:46

UK shareholder meetings calendar - next 7 days

UK shareholder meetings calendar - next 7 days

Read more
29 Dec 2021 15:55

UK dividends calendar - next 7 days

UK dividends calendar - next 7 days

Read more
8 Dec 2021 11:56

Drugmaker Clinigen agrees to Triton's GBP1.2 billion takeover bid

Drugmaker Clinigen agrees to Triton's GBP1.2 billion takeover bid

Read more
8 Dec 2021 11:45

AIM WINNERS & LOSERS: Rockhopper rises as Navitas enters project

AIM WINNERS & LOSERS: Rockhopper rises as Navitas enters project

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.